Advisor Group’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$996K Buy
9,326
+629
+7% +$65.6K 0.01% 1193
2019
Q3
$931K Buy
8,697
+301
+4% +$30.9K 0.01% 1180
2019
Q2
$854K Buy
8,396
+697
+9% +$67K 0.01% 1229
2019
Q1
$693K Sell
7,699
-5,890
-43% -$510K 0.01% 1361
2018
Q4
$1.14M Buy
13,589
+2,107
+18% +$198K 0.01% 891
2018
Q3
$1.24M Sell
11,482
-3,368
-23% -$369K 0.01% 860
2018
Q2
$1.64M Buy
14,850
+111
+0.8% +$11.6K 0.02% 625
2018
Q1
$1.48M Buy
14,739
+324
+2% +$33.2K 0.02% 680
2017
Q4
$1.42M Sell
14,415
-3,940
-21% -$374K 0.02% 706
2017
Q3
$1.72M Buy
18,355
+2,083
+13% +$221K 0.03% 562
2017
Q2
$1.81M Buy
16,272
+1,432
+10% +$151K 0.03% 518
2017
Q1
$1.46M Buy
14,840
+5,728
+63% +$546K 0.03% 562
2016
Q4
$837K Buy
9,112
+21
+0.2% +$1.81K 0.02% 732
2016
Q3
$769K Sell
9,091
-243
-3% -$20.4K 0.02% 747
2016
Q2
$756K Buy
+9,334
New +$711K 0.02% 718

Other funds holding DGX

Advisor Group's DGX Position: Q4 2019 in Review

Advisor Group increased its Quest Diagnostics (DGX) stake by 7.2% in Q4 2019, buying an estimated $65.6K and bringing the position to 9,326 shares worth $996K. The position accounts for 0.01% of the portfolio, ranked #1193.

Advisor Group first reported a position in DGX in Q2 2016 and has held it in 15 quarters since. The position peaked at $1.81M in Q2 2017. 711 funds tracked by Wall St. Rank hold DGX as of Q4 2019.

  • Advisor Group held 9,326 shares of Quest Diagnostics worth $996K as of Q4 2019.
  • Advisor Group bought 629 Quest Diagnostics shares in Q4 2019, an estimated $65.6K.
  • Quest Diagnostics made up 0.01% of Advisor Group's portfolio in Q4 2019, its #1193 holding.
  • Advisor Group first reported a position in Quest Diagnostics in Q2 2016 and has held it in 15 quarters since.
  • Advisor Group's Quest Diagnostics position peaked at $1.81M in Q2 2017.
  • 711 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.